HTLV-1 In Solid-organ Transplantation: Current Challenges And Future ...

Clipboard, Search History, and several other advanced features are temporarily unavailable. Skip to main page content

The .gov means it’s official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation Search: Search Advanced Clipboard Save Email Send to

• Clipboard
• My Bibliography
• Collections
• Citation manager

Display options Display options Format Abstract PubMed PMID

Save citation to file

Format: Summary (text) PubMed PMID Abstract (text) CSV Create file Cancel

Email citation

Email address has not been verified. Go to My NCBI account settings to confirm your email and then refresh this page. To: Subject: Body: Format: Summary Summary (text) Abstract Abstract (text) MeSH and other data Send email Cancel

Add to Collections

• Create a new collection
• Add to an existing collection

Name your collection: Name must be less than 100 characters Choose a collection: Unable to load your collection due to an error Please try again Add Cancel

Add to My Bibliography

• My Bibliography

Unable to load your delegates due to an error Please try again Add Cancel

Your saved search

Name of saved search: Search terms: Test search terms Would you like email updates of new search results? Saved Search Alert Radio Buttons

• Yes
• No

Email: (change) Frequency: Monthly Weekly Daily Which day? The first Sunday The first Monday The first Tuesday The first Wednesday The first Thursday The first Friday The first Saturday The first day The first weekday Which day? Sunday Monday Tuesday Wednesday Thursday Friday Saturday Report format: Summary Summary (text) Abstract Abstract (text) PubMed Send at most: 1 item 5 items 10 items 20 items 50 items 100 items 200 items Send even when there aren't any new results Optional text in email: Save Cancel

Create a file for external citation management software

Create file Cancel

Your RSS Feed

Name of RSS Feed: Number of items displayed: 5 10 15 20 50 100 Create RSS Cancel RSS Link Copy

Full text links

Wolters Kluwer Full text links

Actions

CiteCollectionsAdd to Collections

• Create a new collection
• Add to an existing collection

Name your collection: Name must be less than 100 characters Choose a collection: Unable to load your collection due to an errorPlease try again Add Cancel PermalinkPermalinkCopyDisplay options Display options Format AbstractPubMedPMID

Page navigation

• Title & authors
• Abstract
• Publication types
• MeSH terms
• Substances
• LinkOut - more resources

Title & authors Abstract Publication types MeSH terms Substances LinkOut - more resources Full text links CiteDisplay options Display options Format AbstractPubMedPMID

Abstract

Human T-cell lymphotrophic virus (HTLV)-1 has been reported after solid-organ transplantation, with a related fatal outcome in less than five cases. The natural history of HTLV-1 transmission from donor to recipient is unknown in this setting, because available screening platforms are suboptimal in low-prevalence areas and there is a lack of long-term follow-up. Minimizing organ wastage due to false-positive screening and avoiding donor-derived HTLV-associated diseases remain the goal. To date, only six HTLV-naive organ recipients from four donors (only one had confirmed HTLV) have developed HTLV-associated disease after transplantation. All of these cases were described in countries or from donors from HTLV-endemic regions. To the best of our knowledge, there have been no reported cases of donor-derived HTLV-1-associated death after organ transplantation in the world. Based on data from low-prevalence countries (Europe and the United States) and the current shortage of donor organs, it appears plausible to authorize the decision to transplant an organ without the prior knowledge of the donor's HTLV-1 status. Currently, it is not possible to exclude such transmission and recipients should be informed of the possible inadvertent transmission of this (and other) infections at the time of consent. In those cases where HTLV-1 transmission does occur, there may be a therapeutic window in which use of antiviral agents (i.e., zidovudine and raltegravir) may be of benefit. The development of national/international registries should allow a greater understanding of the extent and consequences of transmission risk and so allow a more evidence-based approach to management.

PubMed Disclaimer

Publication types

• Editorial Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Review Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search

MeSH terms

• Antiviral Agents / therapeutic use Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Biomarkers / blood Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Donor Selection Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Endemic Diseases* Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• HTLV-I Antibodies / blood Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• HTLV-I Infections / diagnosis Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• HTLV-I Infections / drug therapy Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• HTLV-I Infections / mortality Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• HTLV-I Infections / transmission* Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• HTLV-I Infections / virology Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Human T-lymphotropic virus 1 / immunology Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Human T-lymphotropic virus 1 / pathogenicity* Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Humans Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Organ Transplantation / adverse effects* Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Organ Transplantation / mortality Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Organ Transplantation / standards Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Practice Guidelines as Topic Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Predictive Value of Tests Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Prevalence Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Serologic Tests Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Tissue Donors* Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search

Substances

• Antiviral Agents Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Biomarkers Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• HTLV-I Antibodies Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search

LinkOut - more resources

• Full Text Sources

  • Ovid Technologies, Inc.
  • Wolters Kluwer

• Medical

  • MedlinePlus Health Information

Full text links [x] Wolters Kluwer [x] Cite Copy Download .nbib .nbib Format: AMA APA MLA NLM Send To

• Clipboard
• Email
• Save
• My Bibliography
• Collections
• Citation Manager

[x]

NCBI Literature Resources

MeSH PMC Bookshelf Disclaimer

The PubMed wordmark and PubMed logo are registered trademarks of the U.S. Department of Health and Human Services (HHS). Unauthorized use of these marks is strictly prohibited.